Trusted Messenger Intervention
Not Applicable
Terminated
- Conditions
- Vaccine Hesitancy
- Interventions
- Behavioral: Trusted Messenger
- Registration Number
- NCT05167422
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Brief Summary
The objective of this pilot study is to develop and evaluate test a trusted messenger intervention targeting vaccine hesitancy in patients on an inpatient psychiatric hospital setting with both acute and chronic patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 2
Inclusion Criteria
- Able and willing to give verbal informed consent to participate in the study or able to assent with guardian consent
- Expected to remain in the hospital for the duration of the study
- Mental health diagnosis Demographics
- Male, female, or transgender (no exclusion criteria based on gender or sexual orientation)
- Ages 18 or older
- Any race or ethnicity
- English speaking
Exclusion Criteria
- Cognitive impairment sufficient to interfere with participant's ability to provide assent
- People who are non-English speakers or who have major visual or hearing impairment will be excluded given the need to converse with the Trusted Messenger verbally
- People who have received any of the available forms of the COVID-19 vaccine, or those with a medical exemption for receiving the vaccine.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Trusted Messenger Trusted Messenger The trusted messenger patient intervention will involve training a small number of staff "trusted messengers" to engage patients informally and assist with building vaccine confidence in brief one- on-one sessions, supported by trusted messengers weekly consultations with a content expert who can answer specific vaccine related questions that patients have over a 3-week period. Trusted messengers will be full time unit employees, selected with the assistance of the nursing supervisor for having excellent rapport with patients (assessed with the Nurse Coordinator Questionnaire) and for having been vaccinated. Mental health workers or nurses may serve in this role. Both inpatient units involved in this study will be grouped into the same vaccination cohort within the hospital, to provide patients in the intervention and the wait list similar opportunities to be vaccinated.
- Primary Outcome Measures
Name Time Method Vaccine acceptance- This will be measured using the COVID Vaccine Hesitancy Questionnaire Participant is willing to receive the vaccine by the end of week 6 of participation from baseline. The participant is willing to receive the COVID-19 vaccine
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
New Hampshire Hospital
🇺🇸Concord, New Hampshire, United States